Virginia Retirement Systems Et Al Kymera Therapeutics, Inc. Transaction History

Virginia Retirement Systems Et Al

  • $10.1 Billion
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Jul 11, 2023
SELL
$24.84 - $38.75 $67,068 - $104,625
-2,700 Reduced 27.55%
7,100 $210,000
Q4 2022

May 17, 2023
SELL
$19.57 - $30.92 $31,312 - $49,472
-1,600 Reduced 14.04%
9,800 $245 Million
Q3 2022

May 16, 2023
BUY
$20.91 - $34.27 $238,374 - $390,678
11,400 New
11,400 $248 Million

Others Institutions Holding KYMR

# of Institutions
184
Shares Held
64.4M
Call Options Held
50.6K
Put Options Held
81.7K
View Full List

About Kymera Therapeutics, Inc.

KYMR Quotes by TradingView
  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $2.28B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email